Non-Invasive Prenatal Testing Market Insights by Size, Status and Forecast 2025
Non-Invasive Prenatal Testing Comprehensive Study by Type (High & Average Risk, Low Risk), Application (0-12 weeks, 13-24 weeks, 25-36 weeks), Consumables (Assay Kits & Reagents, Disposables), Instruments (Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Other Instruments), Testing (MaterniT21 PLUS, NIFTY, Harmony test, PrenaTest, Panorama test, Verifi, Others) Players and Region - Global Market Outlook to 2024
Edison , NJ -- (SBWire) -- 07/03/2019 --Advance Market Analytics released the research report of Global Non-Invasive Prenatal Testing Market, offers a detailed overview of the factors influencing the global business scope. Non-Invasive Prenatal Testing Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Non-Invasive Prenatal Testing. This Report covers the emerging player's data, including: competitive situation, sales, revenue and global market share of top manufacturers are GE Healthcare (United States), Koninklijke Philips N.V.(Netherlands), Illumina, Inc. (United States), Thermo Fisher Scientific, Inc.(United States), Perkinelmer, Inc. (United States), Sequenom Laboratories (United States), Roche Holding AG (Switzerland), Natera Inc. (United States) and LabCorp (United States).
According to the Center for Disease Control and Prevention, Down syndrome was the most common chromosomal disorder, as about 6000 babies are born with Down syndrome every year in the United States. Additionally, the Organization also stated in 2017, that older mothers were more likely to have a baby affected by Down syndrome than younger mothers.
Free Sample Report + All Related Graphs & Charts @ : https://www.advancemarketanalytics.com/sample-report/29440-global-non-invasive-prenatal-testing-market
Market Drivers
- Increasing Incidence of Chromosome Syndrome and Genetic Abnormalities
Market Trend
- The increasing number of Partnerships and Collaborations focused on innovative Genetic solution analysis, to support the education program, and for the better price and faster availability of tests
Restraints
- Lack of Skilled Professionals
Opportunities
- Accelerated customer adoption of NIPT procedures coupled with the expansion in the Distribution services of the operating entities
Challenges
- Reliability of Test Results Especially in Obese Women.
The Global Non-Invasive Prenatal Testingis segmented by following Product Types:
High & Average Risk, Low Risk
Major applications/end-users industry are:
0-12 weeks, 13-24 weeks, 25-36 weeks
Consumables: Assay Kits & Reagents, Disposables
Instruments: Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Other Instruments
Testing: MaterniT21 PLUS, NIFTY, Harmony test, PrenaTest, Panorama test, Verifi, Others
Top Players in the Market are: GE Healthcare (United States), Koninklijke Philips N.V.(Netherlands), Illumina, Inc. (United States), Thermo Fisher Scientific, Inc.(United States), Perkinelmer, Inc. (United States), Sequenom Laboratories (United States), Roche Holding AG (Switzerland), Natera Inc. (United States) and LabCorp (United States).
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
List of players also available in Coverage: Ivitae (United Status) , Agilent Technologies, Inc.(United States) , BGI Genomics (China) , Quest Diagnostics Incorporation (United States) , Berry Genomics Co.Ltd. (China)
Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/29440-global-non-invasive-prenatal-testing-market
Strategic Points Covered in Table of Content of Global Non-Invasive Prenatal Testing Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Non-Invasive Prenatal Testing market
Chapter 2: Exclusive Summary – the basic information of the Non-Invasive Prenatal Testing Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Non-Invasive Prenatal Testing
Chapter 4: Presenting the Non-Invasive Prenatal Testing Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region 2013-2018
Chapter 6: Evaluating the leading manufacturers of the Non-Invasive Prenatal Testing market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
Finally, Non-Invasive Prenatal Testing Market is a valuable source of guidance for individuals and companies.
Data Sources & Methodology
The primary sources involves the industry experts from the Global Non-Invasive Prenatal Testing Market including the management organizations, processing organizations, analytics service providers of the industry's value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.
In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.
Get More Information: https://www.advancemarketanalytics.com/reports/29440-global-non-invasive-prenatal-testing-market
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
About Author:
Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies' revenues.
Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.
Contact Us:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@advancemarketanalytics.com
Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport
Media Relations Contact
Craig Francis
PR & Marketing Manager
AMA Research & Media LLP
1-206-317-1218
https://www.advancemarketanalytics.com
View this press release online at: http://rwire.com/1242424